2024 ICD-10-CM Diagnosis Code C62

by

Malignant neoplasm of testis

  • C62 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
  • The 2024 edition of ICD-10-CM C62 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of C62 – other international versions of ICD-10 C62 may differ.

Use Additional

  • code to identify any functional activity

The following code(s) above C62 contain annotation back-references

 that may be applicable to C62:

  • C00-D49  Neoplasms
  • C60-C63  Malignant neoplasms of male genital organs

Clinical Information

  • A primary or metastatic malignant neoplasm involvingf the testis
  • Testicular cancer forms in a man’s testicles, the two egg-shaped glands that produce sperm and testosterone. Testicular cancer mainly affects young men between the ages of 20 and 39. It is also more common in men who
    • have had abnormal testicle development
    • have had an undescended testicle
    • have a family history of the cancer
    symptoms include pain, swelling or lumps in your testicles or groin area. Most cases can be treated, especially if it is found early. Treatment options include surgery, radiation and/or chemotherapy. Regular exams after treatment are important. Treatments may also cause infertility. If you may want children later on, you should consider sperm banking before treatment. nih: national cancer institute

Code History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change

Code annotations containing back-references to C62:

  • Type 1 Excludes: C75